Pricing Log in Create free account
Wednesday 14 October 2026 Export CVS’s income statement to Excel — free account

CVS Health Corporation

CVS Healthcare Healthcare Plans

CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024. In the quarter to June 2026, revenue grew 7.26%, EPS grew 187.7%, free cash flow grew 338.3% and total debt fell 7.64%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten.

87.65 0.09 −0.10%
Market cap
$112.2B
P/E
22.9×
Fwd P/E
15.4×
Dividend yield
3.79%
F-score
7/9
Altman Z
2.26
Beneish M
−2.64
Dividend safety
43/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

CVS Health Corporation (CVS) SEC filings, changes and red flags

Red flags

  • Officer departure

    CVS Health Corporation reported the departure of an officer or director

    8-K filed · The filing · sec.gov

  • Impairment

    CVS Health Corporation recorded a goodwill impairment of $5.7 billion in fiscal Q3 2025

    10-Q filed · The filing · sec.gov

Filings

Form Period Filed What it reports Flags
8-K Aug 13, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits Officer departure
10-Q Jun 30, 2026 P1I2: 29 added · 10 removed · 34 modified
P2I1A: no material changes, the filing says
8-K Aug 5, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K May 14, 2026 5.02 Departure or appointment of directors or officers; 5.07 Submission of matters to a vote of security holders
10-Q Mar 31, 2026
8-K May 6, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Mar 18, 2026 5.02 Departure or appointment of directors or officers
10-K Dec 31, 2025 1: 16 added · 52 removed · 117 modified
1A: 10 added · 50 removed · 108 modified
7: 30 added · 49 removed · 61 modified
8-K Feb 10, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Dec 9, 2025 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Nov 20, 2025 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025 Impairment
8-K Oct 29, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Sep 22, 2025 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025
10-K Dec 31, 2024

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.